title: Natural products from myxobacteria: novel metabolites and bioactivities.
abstract: Covering: 2011-July 2016Myxobacteria are a rich source for structurally diverse secondary metabolites with intriguing biological activities. Here we report on new natural products that were isolated from myxobacteria in the period of 2011 to July 2016. Some examples of recent advances on modes-of-action are also summarised along with a more detailed overview on five compound classes currently assessed in preclinical studies.
authors.affiliation: Helmholtz Institute for Pharmaceutical Research Saarland, Department of Microbial Natural Products, Helmholtz Centre for Infection Research and Department of Pharmaceutical Biotechnology, Saarland University, Campus E8.1, 66123 Saarbrücken, Germany. rolf.mueller@helmholtz-hzi.de.
authors.forename: J
authors.initials: J
authors.lastname: Herrmann
authors.forename: A Abou
authors.initials: AA
authors.lastname: Fayad
authors.forename: R
authors.initials: R
authors.lastname: Müller
mesh_terms: D001688:Biological Products / Q000737:chemistry / Q000302:isolation & purification* / Q000494:pharmacology*; D015394:Molecular Structure; D009231:Myxococcales / Q000737:chemistry*
chemical_list: D001688:Biological Products